March 27, 2007; 68 (13) Article
The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy
M. A. Nagel, B. Forghani, R. Mahalingam, M. C. Wellish, R. J. Cohrs, A. N. Russman, I. Katzan, R. Lin, C. J. Gardner, D. H. Gilden
First published February 7, 2007, DOI: https://doi.org/10.1212/01.wnl.0000258549.13334.16
M. A. Nagel
From the Departments of Neurology (M.A.N., R.M., M.C.W., R.J.C., D.H.G.) and Microbiology (D.H.G), University of Colorado Health Sciences Center, Denver; Viral and Rickettsial Disease Laboratory (B.F.), Division of Communicable Disease Control, California Department of Health Services, Richmond; Department of Neurology (A.N.R., I.K., R.L.), Cleveland Clinic Foundation, OH; and Department of Neurology (C.J.G.), Thomas Jefferson University School of Medicine, Philadelphia, PA.
B. Forghani
From the Departments of Neurology (M.A.N., R.M., M.C.W., R.J.C., D.H.G.) and Microbiology (D.H.G), University of Colorado Health Sciences Center, Denver; Viral and Rickettsial Disease Laboratory (B.F.), Division of Communicable Disease Control, California Department of Health Services, Richmond; Department of Neurology (A.N.R., I.K., R.L.), Cleveland Clinic Foundation, OH; and Department of Neurology (C.J.G.), Thomas Jefferson University School of Medicine, Philadelphia, PA.
R. Mahalingam
From the Departments of Neurology (M.A.N., R.M., M.C.W., R.J.C., D.H.G.) and Microbiology (D.H.G), University of Colorado Health Sciences Center, Denver; Viral and Rickettsial Disease Laboratory (B.F.), Division of Communicable Disease Control, California Department of Health Services, Richmond; Department of Neurology (A.N.R., I.K., R.L.), Cleveland Clinic Foundation, OH; and Department of Neurology (C.J.G.), Thomas Jefferson University School of Medicine, Philadelphia, PA.
M. C. Wellish
From the Departments of Neurology (M.A.N., R.M., M.C.W., R.J.C., D.H.G.) and Microbiology (D.H.G), University of Colorado Health Sciences Center, Denver; Viral and Rickettsial Disease Laboratory (B.F.), Division of Communicable Disease Control, California Department of Health Services, Richmond; Department of Neurology (A.N.R., I.K., R.L.), Cleveland Clinic Foundation, OH; and Department of Neurology (C.J.G.), Thomas Jefferson University School of Medicine, Philadelphia, PA.
R. J. Cohrs
From the Departments of Neurology (M.A.N., R.M., M.C.W., R.J.C., D.H.G.) and Microbiology (D.H.G), University of Colorado Health Sciences Center, Denver; Viral and Rickettsial Disease Laboratory (B.F.), Division of Communicable Disease Control, California Department of Health Services, Richmond; Department of Neurology (A.N.R., I.K., R.L.), Cleveland Clinic Foundation, OH; and Department of Neurology (C.J.G.), Thomas Jefferson University School of Medicine, Philadelphia, PA.
A. N. Russman
From the Departments of Neurology (M.A.N., R.M., M.C.W., R.J.C., D.H.G.) and Microbiology (D.H.G), University of Colorado Health Sciences Center, Denver; Viral and Rickettsial Disease Laboratory (B.F.), Division of Communicable Disease Control, California Department of Health Services, Richmond; Department of Neurology (A.N.R., I.K., R.L.), Cleveland Clinic Foundation, OH; and Department of Neurology (C.J.G.), Thomas Jefferson University School of Medicine, Philadelphia, PA.
I. Katzan
From the Departments of Neurology (M.A.N., R.M., M.C.W., R.J.C., D.H.G.) and Microbiology (D.H.G), University of Colorado Health Sciences Center, Denver; Viral and Rickettsial Disease Laboratory (B.F.), Division of Communicable Disease Control, California Department of Health Services, Richmond; Department of Neurology (A.N.R., I.K., R.L.), Cleveland Clinic Foundation, OH; and Department of Neurology (C.J.G.), Thomas Jefferson University School of Medicine, Philadelphia, PA.
R. Lin
From the Departments of Neurology (M.A.N., R.M., M.C.W., R.J.C., D.H.G.) and Microbiology (D.H.G), University of Colorado Health Sciences Center, Denver; Viral and Rickettsial Disease Laboratory (B.F.), Division of Communicable Disease Control, California Department of Health Services, Richmond; Department of Neurology (A.N.R., I.K., R.L.), Cleveland Clinic Foundation, OH; and Department of Neurology (C.J.G.), Thomas Jefferson University School of Medicine, Philadelphia, PA.
C. J. Gardner
From the Departments of Neurology (M.A.N., R.M., M.C.W., R.J.C., D.H.G.) and Microbiology (D.H.G), University of Colorado Health Sciences Center, Denver; Viral and Rickettsial Disease Laboratory (B.F.), Division of Communicable Disease Control, California Department of Health Services, Richmond; Department of Neurology (A.N.R., I.K., R.L.), Cleveland Clinic Foundation, OH; and Department of Neurology (C.J.G.), Thomas Jefferson University School of Medicine, Philadelphia, PA.
D. H. Gilden
From the Departments of Neurology (M.A.N., R.M., M.C.W., R.J.C., D.H.G.) and Microbiology (D.H.G), University of Colorado Health Sciences Center, Denver; Viral and Rickettsial Disease Laboratory (B.F.), Division of Communicable Disease Control, California Department of Health Services, Richmond; Department of Neurology (A.N.R., I.K., R.L.), Cleveland Clinic Foundation, OH; and Department of Neurology (C.J.G.), Thomas Jefferson University School of Medicine, Philadelphia, PA.
The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy
M. A. Nagel, B. Forghani, R. Mahalingam, M. C. Wellish, R. J. Cohrs, A. N. Russman, I. Katzan, R. Lin, C. J. Gardner, D. H. Gilden
Neurology Mar 2007, 68 (13) 1069-1073; DOI: 10.1212/01.wnl.0000258549.13334.16
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 68 no. 13 1069-1073
PubMed:
Print ISSN:
Online ISSN:
History:
- First Published February 7, 2007.
Article Versions
- Previous version (February 7, 2007 - 13:00).
- You are viewing the most recent version of this article.
Copyright & Usage:
© 2007
Author Disclosures
- M. A. Nagel, MD,
- B. Forghani, PhD,
- R. Mahalingam, PhD,
- M. C. Wellish, BS,
- R. J. Cohrs, PhD,
- A. N. Russman, DO,
- I. Katzan, MD,
- R. Lin, MD,
- C. J. Gardner, DO and
- D. H. Gilden, MD
- M. A. Nagel, MD,
- B. Forghani, PhD,
- R. Mahalingam, PhD,
- M. C. Wellish, BS,
- R. J. Cohrs, PhD,
- A. N. Russman, DO,
- I. Katzan, MD,
- R. Lin, MD,
- C. J. Gardner, DO and
- D. H. Gilden, MD
- From the Departments of Neurology (M.A.N., R.M., M.C.W., R.J.C., D.H.G.) and Microbiology (D.H.G), University of Colorado Health Sciences Center, Denver; Viral and Rickettsial Disease Laboratory (B.F.), Division of Communicable Disease Control, California Department of Health Services, Richmond; Department of Neurology (A.N.R., I.K., R.L.), Cleveland Clinic Foundation, OH; and Department of Neurology (C.J.G.), Thomas Jefferson University School of Medicine, Philadelphia, PA.
- Address correspondence and reprint requests to Dr Gilden at Department of Neurology, Mail Stop B182, University of Colorado Health Sciences Center, 4200 E. 9 Ave., Denver, CO 80262; e-mail: don.gilden{at}uchsc.edu
Article usage
Cited By...
Letters: Rapid online correspondence
No comments have been published for this article.
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Dr. Jeffrey Allen and Dr. Nicholas Purcell
► Watch
Alert Me
Recommended articles
-
Articles
The varicella zoster virus vasculopathiesClinical, CSF, imaging, and virologic featuresM. A. Nagel, R. J. Cohrs, R. Mahalingam et al.Neurology, March 10, 2008 -
Clinical and Ethical Challenges
The challenging patient with varicella-zoster virus diseaseMaria A. Nagel, Don Gilden et al.Neurology: Clinical Practice, April 15, 2013 -
Article
Varicella-zoster virus vasculopathyImmune characteristics of virus-infected arteriesMaria A. Nagel, Igor Traktinskiy, Kurt R. Stenmark et al.Neurology, December 12, 2012 -
Articles
Varicella zoster virus vasculopathyAnalysis of virus-infected arteriesM.A. Nagel, I. Traktinskiy, Y. Azarkh et al.Neurology, July 13, 2011